Evaluate provides trusted commercial intelligence and forecasting models for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global biopharma market to drive better decisions.
Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action.
Evaluate Pharma - the trusted global view of the pharmaceutical market’s past, present and future performance with consensus forecasts to 2030, company financials, pipelines, deals and more.
Evaluate Omnium - provides a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, delivering game-changing insight into pharma asset potential.
Forecasting Solutions - Ensure precise and efficient forecasting at every stage of your product lifecycle. Our comprehensive suite of forecasting solutions tailored to the pharmaceutical industry, including software, cloud-based platforms, custom-built models, advanced analytics and data. Our forecasting solutions support forecasters through new product planning, launch, and commercialisation.
CDMO Intelligence - Access CDMO screening, molecular landscape insights, detailed manufacturing capabilities, and accurate volume forecasts. You’ll have a wealth of data and industry insights at your fingertips, backed by gold standard financial forecast methodologies.
Consulting and Analytics - Evaluate’s consulting and analytics team is here to help clients address unique scientific, clinical and commercial challenges. We answer key asset, portfolio strategy, and corporate strategy-related business questions, powered by the combined resources of Norstella, one of the world’s largest pharma intelligence solutions providers.
Evaluate’s combination of leading data sources, deep pharma expertise, robust methodologies, data science and real-world data will ensure your teams make the right decisions to drive your growth.
Rating Reviews
Rating is calculated based on
1
review and is evolving.
Pros: The company culture at Evaluate is definitely a highlight. Everyone, from colleagues to management, is incredibly supportive and collaborative. As a Data Analyst in the life sciences sector, I've had fantastic opportunities to learn new tools and methodologies, contributing to valuable market intelligence projects. The focus on teamwork really helps you feel connected and makes daily tasks more enjoyable. It's a professional yet friendly environment.
Cons: While overall communication is good, sometimes during peak project times, information flow can be a bit slower, especially between different departments in this global private company. Improving some internal approval processes could also streamline workflow, but these are minor points. Workload can be high during release cycles, which is common in data analytics.
Advice to Management: Continue to foster the strong, collaborative company culture and invest in enhancing inter-departmental communication, especially during high-growth or peak project phases. Streamlining some internal processes would also be beneficial.
Show more
What kind of benefits does Evaluate Ltd. offer to its employees, especially for those in London?
Evaluate Ltd. in London provides a good benefits package, including competitive health insurance, a generous pension scheme, and opportunities for professional development which really helped me grow in my role.
UK
